STE

STERIS PLC

Healthcare • USA

Apr 05 • 04:00PM ET
251.59
+4.71 (+1.91%)
Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It als ... read more

Full Time Employees 18,000
Phone 353 1 232 2000
Website https://www.steris.com
CEO Mr. Daniel A. Carestio
IPO Date 1992-06-01
Sector Healthcare
Industry Medical - Devices
Address 70 Sir John Rogerson’s Quay, Dublin, None D02 R296
Balance Sheet
Total Cash $155,178,000
Total Debt $2,319,893,000
Current Ratio 2.13
Quick Ratio 1.20
Profitability
Gross Margin 43.38%
Net Margin 9.18%
ROE 7.29%
ROA 4.67%
ROIC 7.59%
Balance Sheet
Total Cash $155,178,000
Total Debt $2,319,893,000
Current Ratio 2.13
Quick Ratio 1.20
Profitability
Gross Margin 43.38%
Net Margin 9.18%
ROE 7.29%
ROA 4.67%
ROIC 7.59%
Name STERIS PLC Sector Healthcare Currency USD Relative Volume 2.19 Market Cap 20889
Current Ratio 2.13 Dividend / Share 2.18 EPS 4.72 Revenue 5095138000 P/S 4.1
P/E 44.7 Beta 0.38 Income 467592000 Volume 1200846 Average Volume 547340
Distance to 200DMA -5.15% 200 DMA 224.15 50 DMA 223.16 ROA 4.5 ROE 7.3
Distance to 50DMA -4.73% Return 1Y -0.88% Return YTD 3.7% Forward PE Qtly Growth YOY
Debt/Eq 0.56 P/B 3.3 Dividend Yield 1.1% Net Margin 9.18% Payout Ratio 46.0
Performance
52 Week Range 46.0%
Distance to 200DMA 0.43%
Day Change Percent $1.09
Performance Week $0.57
Performance Month $0.57
Performance Quarter 2024-09-05
Performance YTD $0.57
Performance Year $0.57

Performance Range

Day

$196
Current
Low: High:
Month

$196
Current
Low: High:
Month

$196
Current
Low: High:
Month

$196
Current
Low: High:
Month

$196
Current
Low: High:
Balance Sheet
Total Cash $172,195,000
Total Debt $2,399,815,000
Current Ratio 2.41%
Quick Ratio 1.36%
Profitability
Gross Margin 43.38%
Net Margin 9.18%
ROE 7.29%
ROA 4.67%
ROIC 7.59%
Valuation
Price to Earnings 53.11
Price to Book 3.87
Price to Sales 4.87
Price to Free Cash Flow 33.05
Dividends
Payout Ratio 46.02%
Dividend Yield 0.87%
Dividend Amount $1.09
Last Dividend Pay Date 2024-09-05
Last Dividend Paid $0.57
Performance
52 Week Range 46.0%
Distance to 200DMA 0.43%
Day Change Percent $1.09
Performance Week $0.57
Performance Month $0.57
Performance Quarter 2024-09-05
Performance YTD $0.57
Performance Year $0.57
Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It als ... read more

Full Time Employees 18,000
Phone 353 1 232 2000
Website https://www.steris.com
CEO Mr. Daniel A. Carestio
IPO Date 1992-06-01
Sector Healthcare
Address 70 Sir John Rogerson’s Quay, Dublin, None D02 R296
Histogram - Daily

Balance Sheet
Total Cash $172,195,000
Total Debt $2,399,815,000
Current Ratio 2.41%
Quick Ratio 1.36%
Profitability
Gross Margin 0.4300%
Net Margin 0.0850%
ROE 0.07%
ROA 0.04%
Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It als ... read more

Full Time Employees 18,000
Phone 353 1 232 2000
Website https://www.steris.com
CEO Mr. Daniel A. Carestio
IPO Date 1992-06-01
Sector Healthcare
Address 70 Sir John Rogerson’s Quay, Dublin, None D02 R296
Monthly Win Rate

Balance Sheet (Multi-Column Example)
Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023
Cash & Short Term Investments 53,775.0 65,171.0 61,801.0 67,150.0 73,100.0 61,555.0 62,482.0 55,872.0
Receivables 59,306.0 66,243.0 43,172.0 41,150.0 50,102.0 60,985.0 39,186.0 35,899.0
Inventory 6,911.0 7,286.0 6,165.0 6,232.0 6,511.0 6,331.0 7,351.0 7,482.0

Latest News

Steris: May Benefit From Bringing Pharmaceutical Manufacturing Back To The U.S.
Steris: May Benefit From Bringing Pharmaceutical Manufacturing Back To The U.S.

Steris plc remains a Strong Buy with a fair value of $281, supported by robust organic growth and margin expansion. The Trump administration's push to reshore pharma manufacturing could be a major tai

2025-05-15 16:27:07 - seekingalpha.com
STERIS plc (STE) Q4 2025 Earnings Call Transcript
STERIS plc (STE) Q4 2025 Earnings Call Transcript

STERIS plc (NYSE:STE ) Q4 2025 Results Conference Call May 15, 2025 9:00 AM ET Company Participants Julie Winter - Investor Relations Mike Tokich - Senior Vice President and Chief Financial Officer Da

2025-05-15 13:52:08 - seekingalpha.com
STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket
STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket

STERIS' fourth-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues.

2025-05-15 09:41:04 - zacks.com
Here's What Key Metrics Tell Us About Steris (STE) Q4 Earnings
Here's What Key Metrics Tell Us About Steris (STE) Q4 Earnings

Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street es

2025-05-14 19:30:32 - zacks.com
Steris (STE) Surpasses Q4 Earnings Estimates
Steris (STE) Surpasses Q4 Earnings Estimates

Steris (STE) came out with quarterly earnings of $2.74 per share, beating the Zacks Consensus Estimate of $2.59 per share. This compares to earnings of $2.41 per share a year ago.

2025-05-14 18:45:24 - zacks.com
Steris forecasts annual profit above estimates on strong medical equipment sales
Steris forecasts annual profit above estimates on strong medical equipment sales

Medical equipment maker Steris forecast annual profit above analysts' estimate on Wednesday, banking on strength in its biggest segment that sells sterilization products, sending its shares up more th

2025-05-14 17:26:52 - reuters.com
Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers
Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers

Medical equipment maker Steris (STE) on Wednesday afternoon reported fiscal fourth-quarter 2025 financial results. A summary of its key numbers is below.

2025-05-14 17:06:05 - investopedia.com
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year

DUBLIN, IRELAND, May 14, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 fourth quarter and full year ended March 31,

2025-05-14 16:30:00 - globenewswire.com
What Analyst Projections for Key Metrics Reveal About Steris (STE) Q4 Earnings
What Analyst Projections for Key Metrics Reveal About Steris (STE) Q4 Earnings

Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some o

2025-05-09 10:20:51 - zacks.com
STERIS Declares Dividend of $0.57 per share
STERIS Declares Dividend of $0.57 per share

DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. T

2025-05-07 16:30:00 - globenewswire.com
10 Undervalued Dividend Growth Stocks: May 2025
10 Undervalued Dividend Growth Stocks: May 2025

I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and anoth

2025-05-07 09:00:00 - seekingalpha.com
Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates?
Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates?

STERIS is expected to have experienced an increase in bioprocessing demand in the fourth quarter.

2025-05-06 14:10:37 - zacks.com
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Fi

DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and

2025-04-22 16:30:00 - globenewswire.com
Is it the Right Time to Hold STERIS Stock in Your Portfolio?
Is it the Right Time to Hold STERIS Stock in Your Portfolio?

STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment.

2025-04-16 11:25:40 - zacks.com
Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'
Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'

Upgraded Steris to 'strong buy' with a fair value of $254 per share due to strong recovery in its Applied Sterilization Technologies (AST) business. AST segment showed 9.5% organic growth, with manage

2025-03-22 07:22:30 - seekingalpha.com
Steris (STE) Up 3% Since Last Earnings Report: Can It Continue?
Steris (STE) Up 3% Since Last Earnings Report: Can It Continue?

Steris (STE) reported earnings 30 days ago. What's next for the stock?

2025-03-07 12:36:21 - zacks.com